Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Cash & Cash Equivalents
The cash for Labcorp Holdings Inc. (LH) is $532.30 Million with a year-over-year change of -64.95%. Cash and cash equivalents include currency, bank deposits, and highly liquid investments that can be quickly converted to cash.
LH Cash Chart
LH Cash
$532.30M+1072.47% 20Y
Zoom
Current Cash
$532.30M
$532.30 Million
Year-over-Year Change
-64.95%
vs. $1.52B prior year
Historical Data
30
Years of data available
Annual Cash History
| Year | Cash | YoY Change | % Change |
|---|---|---|---|
| 2025 | $532.30M | $-986.40M | -64.95% |
| 2024 | $1.52B | +$981.90M | +182.92% |
| 2023 | $536.80M | +$216.20M | +67.44% |
| 2022 | $320.60M | $-1.15B | -78.23% |
| 2021 | $1.47B | +$151.90M | +11.50% |
| 2020 | $1.32B | +$983.30M | +291.35% |
| 2019 | $337.50M | $-89.30M | -20.92% |
| 2018 | $426.80M | +$110.20M | +34.81% |
| 2017 | $316.60M | $-117.00M | -26.98% |
| 2016 | $433.60M | $-282.80M | -39.48% |
| 2015 | $716.40M | +$136.40M | +23.52% |
| 2014 | $580.00M | +$176.00M | +43.56% |
| 2013 | $404.00M | $-62.80M | -13.45% |
| 2012 | $466.80M | +$307.50M | +193.03% |
| 2011 | $159.30M | $-71.40M | -30.95% |
| 2010 | $230.70M | +$82.20M | +55.35% |
| 2009 | $148.50M | $-71.20M | -32.41% |
| 2008 | $219.70M | +$163.30M | +289.54% |
| 2007 | $56.40M | +$4.90M | +9.51% |
| 2006 | $51.50M | +$6.10M | +13.44% |
| 2005 | $45.40M | $-141.40M | -75.70% |
| 2004 | $186.80M | +$63.80M | +51.87% |
| 2003 | $123.00M | +$66.60M | +118.09% |
| 2002 | $56.40M | $-92.80M | -62.20% |
| 2001 | $149.20M | +$100.40M | +205.74% |
| 2000 | $48.80M | +$8.50M | +21.09% |
| 1999 | $40.30M | +$17.60M | +77.53% |
| 1998 | $22.70M | $-600,000 | -2.58% |
| 1997 | $23.30M | $-6.00M | -20.48% |
| 1996 | $29.30M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter